ArticleCell death & disease2020

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.

Chen Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.